
%0 Journal Article
%A Vozikis, Athanassios 
%A Goulionis, John E 
%T Medical decision making for patients with Parkinson disease under Average Cost Criterion
%J Australia and New Zealand Health Policy
%D 2009/12/30
%V 6
%N 1
%P -
%K 
%R https://doi.org/10.1071/HP090615
%U https://www.publish.csiro.au/paper/HP090615 
%X Parkinson's disease (PD) is one of the most common disabling neurological disorders and results in substantial burden for patients, their families and the as a whole society in terms of increased health resource use and poor quality of life. For all stages of PD, medication therapy is the preferred medical treatment. The failure of medical regimes to prevent disease progression and to prevent long-term side effects has led to a resurgence of interest in surgical procedures. Partially observable Markov decision models (POMDPs) are a powerful and appropriate technique for decision making. In this paper we applied the model of POMDP's as a supportive tool to clinical decisions for the treatment of patients with Parkinson's disease. The aim of the model was to determine the critical threshold level to perform the surgery in order to minimize the total lifetime costs over a patient's lifetime (where the costs incorporate duration of life, quality of life, and monetary units). Under some reasonable conditions reflecting the practical meaning of the deterioration and based on the various diagnostic observations we find an optimal average cost policy for patients with PD with three deterioration levels. 
